The repair of gamma-radiation-induced DNA damage is inhibited by microcystin-LR, the PP1 and PP2A phosphatase inhibitor

Mutagenesis. 2006 Jan;21(1):83-90. doi: 10.1093/mutage/gel002. Epub 2006 Jan 24.

Abstract

The genotoxic activity of microcystin-LR (MC-LR) is a matter of debate. MC-LR is known to be a phosphatase inhibitor and it may be expected that it is involved in the regulation of the activity of DNA-dependent protein kinase (DNA-PK), the key enzyme involved in the repair of radiation-induced DNA damage. We studied the effect of MC-LR on the repair capacity of radiation-induced DNA damage in human lymphocytes and human glioblastoma cell lines MO59J and MO59K. A dose of 0.5 microg/ml of MC-LR was chosen because it induced very little early apoptosis which gives no false positive results in the comet assay. Human lymphocytes in G0-phase of the cell cycle were pre-treated with MC-LR for 3 h and irradiated with 2 Gy of gamma radiation. The kinetics of DNA repair was assessed by the comet assay. In addition the frequencies of chromosomal aberrations were analysed. The pre-treatment with MC-LR inhibited the repair of radiation-induced damage and lead to enhanced frequencies of chromosomal aberrations including dicentric chromosomes. The results of a split-dose experiment, where cells were exposed to two 1.5 Gy doses of radiation separated by 3 h with or without MC-LR, confirmed that the toxin increased the frequency of dicentric chromosomes. We also determined the effect of MC-LR and ionizing radiation on the frequency of gamma-H2AX foci. The pre-treatment with MC-LR resulted in reduced numbers of gamma-H2AX foci in irradiated cells. In order to elucidate the impact of MC-LR on DNA-PK we examined the kinetics of DNA repair in human glioblastoma MO59J and MO59K cells. Both cell lines were exposed to 10 Gy of X-rays and DNA repair was analysed by the comet assay. A strong inhibitory effect was observed in the MO59K but not in the MO59J cells. These results indicate that DNA-PK might be involved in DNA repair inhibition by MC-LR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / radiation effects
  • Chromosome Aberrations
  • Comet Assay
  • DNA Damage* / drug effects
  • DNA Damage* / radiation effects
  • DNA Repair* / drug effects
  • DNA Repair* / radiation effects
  • DNA-Activated Protein Kinase / metabolism
  • Enzyme Inhibitors / adverse effects*
  • Flow Cytometry
  • Gamma Rays / adverse effects*
  • Glioblastoma / drug therapy
  • Glioblastoma / pathology
  • Glioblastoma / radiotherapy
  • Histones / metabolism
  • Humans
  • Kinetics
  • Lymphocytes / cytology
  • Lymphocytes / drug effects
  • Lymphocytes / radiation effects
  • Marine Toxins / adverse effects
  • Microcystins
  • Peptides, Cyclic / adverse effects*
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Receptors, Neuropeptide Y / antagonists & inhibitors
  • Resting Phase, Cell Cycle / drug effects
  • Resting Phase, Cell Cycle / radiation effects

Substances

  • Enzyme Inhibitors
  • H2AX protein, human
  • Histones
  • Marine Toxins
  • Microcystins
  • Peptides, Cyclic
  • Receptors, Neuropeptide Y
  • neuropeptide Y4 receptor
  • DNA-Activated Protein Kinase
  • Phosphoprotein Phosphatases
  • cyanoginosin LR